EUROPE NEUROSTIMULATION DEVICE MARKET 2019-2027

Lifesciences | Medical Devices & Consumables

EUROPE NEUROSTIMULATION DEVICE MARKET 2019-2027

Market By System, Application, And Geography | Forecast 2019-2027

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

According to Triton, the research on the Europe neurostimulation device market is estimated to record a significant growth at a CAGR of 9.58% over the forecast period 2019-2027.

Countries that are studied in Europe’s neurostimulation device market are:

•           The United Kingdom

•           France

•           Germany

•           Spain

•           Italy

•           Russia

•           Rest of Europe

Report scope can be customized per your requirements. Request For Customization

The increase in the number of individuals affected by chronic pain, emerging public awareness, and coverage of neurostimulation devices are driving the market growth in Europe. Moreover, the coverage of neurostimulation devices and the rise in public awareness and are also fueling the market growth. According to the World Health Organization (WHO), around 3 million individuals suffer from epilepsy and over 150,000 new cases are diagnosed per year, which is expected to result in the adoption of neurostimulation devices. Additionally, the clinical evidence of neurostimulation devices is likely to increase when compared to drug therapy during the forecasted period.

Germany is predicted to grow with the highest CAGR over the forecasting years. There is an increasing prevalence of depression among adolescents. According to Barmer, a German health insurance company, about 470,000 German students have been suffering from mental disorders. This has led to the growth in health expenses for the treatment of these diseases and is offering lucrative opportunities to propel the neurostimulation device market growth.

In Spain, the demand for neurostimulation devices is anticipated to rise due to the high pervasiveness of Alzheimer’s disease. The country is making efforts to improve the overall quality of life of the patients. This would help them to return to their highest level of function and independence, thereby boosting the adoption of neurostimulation devices in the country.

Hocoma AG is a global company that designs, manufactures, develops, and commercializes automated therapy equipment for the rehabilitation of patients suffering from neurological movement disorders. The company offers a wide range of products that are used to treat neurological patients with movement disorders caused by stroke, multiple sclerosis, spinal cord injury, traumatic brain injury, and various neurological diseases. The company operates in Europe, North and Latin America, Asia-Pacific, and the Middle East and Africa.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT
ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET 2022-2028
Lifesciences

ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET 2022-2028

Market by Type, Application, E ..

VIEW REPORT

Table of Content

1.    EUROPE NEUROSTIMULATION DEVICE MARKET – SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES MODEL

2.2.1.   THREAT OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTES

2.2.3.   BARGAINING POWER OF SUPPLIERS

2.2.4.   BARGAINING POWER OF BUYERS

2.2.5.   THREAT OF RIVALRY

2.3. VALUE CHAIN OUTLOOK

2.4. MARKET TRENDS

2.5. MARKET SHARE OUTLOOK

2.6. PESTLE OUTLOOK

2.7. MARKET ATTRACTIVENESS INDEX

2.8. KEY INSIGHT

2.9. MARKET DRIVERS

2.9.1.   RISING INCIDENCE OF NEURO DISEASES

2.9.2.   INCREASING GERIATRIC POPULATION

2.9.3.   GROWING DEMAND FOR MRI SCANS

2.9.4.   FAVORABLE REIMBURSEMENT POLICIES

2.10.            MARKET RESTRAINTS

2.10.1.                HIGH COST OF NEUROMODULATION TREATMENT

2.10.2.                PRESENCE OF ALTERNATIVE THERAPY

2.11.            MARKET OPPORTUNITIES

2.11.1.                HIGH MARKET POTENTIAL FOR SCS DEVICES IN NEUROSTIMULATION

2.11.2.                TECHNOLOGICAL DEVELOPMENT

2.11.3.                GROWING INCIDENCE OF CHRONIC DISCOMFORT

2.12.            MARKET CHALLENGES

2.12.1.                STRINGENT REGULATORY APPROVALS

2.12.2.                SIDE EFFECTS OF ASSOCIATED NEUROSTIMULATION DEVICES

3.    NEUROSTIMULATION DEVICE MARKET OUTLOOK – BY SYSTEM

3.1. SPINAL CORD STIMULATORS (SCS)

3.2. DEEP BRAIN STIMULATORS (DBS)

3.3. SACRAL NERVE STIMULATORS (SNS)

3.4. VAGUS NERVE STIMULATORS (VNS)

3.5. GASTRIC ELECTRIC STIMULATOR

3.6. OTHER SYSTEM

4.    NEUROSTIMULATION DEVICE MARKET OUTLOOK – BY APPLICATIONS

4.1. PAIN MANAGEMENT

4.2. EPILEPSY

4.3. ESSENTIAL TREMOR

4.4. URINARY AND FECAL INCONTINENCE

4.5. DEPRESSION

4.6. DYSTONIA

4.7. GASTROPARESIS

4.8. PARKINSON’S DISEASE

4.9. OTHER APPLICATIONS

5.    NEUROSTIMULATION DEVICE MARKET – REGIONAL OUTLOOK

5.1.1.   COUNTRY ANALYSIS

5.1.1.1.      THE UNITED KINGDOM

5.1.1.2.      FRANCE

5.1.1.3.      GERMANY

5.1.1.4.      SPAIN

5.1.1.5.      ITALY

5.1.1.6.      RUSSIA

5.1.1.7.      REST OF EUROPE

6.    COMPANY PROFILES

6.1. NEURONETICS, INC.

6.2. ST. JUDE MEDICAL, INC. (ACQUIRED BY ABBOTT LABORATORIES)

6.3. HOCOMA AG

6.4. NEVRO CORP.

6.5. CYBERONICS INC.

6.6. COGENTIX MEDICAL, INC.

6.7. DEPUY SYNTHES COMPANIES

6.8. DR. LANGER MEDICAL GMBH

6.9. MEDTRONIC PLC

6.10.            THE MAGSTIM COMPANY LIMITED

6.11.            ECTRON LIMITED

6.12.            BOSTON SCIENTIFIC CORPORATION

6.13.            EKSO BIONICS HOLDING INC.

6.14.            ALEVA NEUROTHERAPEUTICS SA

6.15.            HELIUS MEDICAL TECHNOLOGIES

7.    RESEARCH METHODOLOGY & SCOPE

7.1. RESEARCH SCOPE & DELIVERABLES

7.1.1.   OBJECTIVES OF STUDY

7.1.2.   SCOPE OF STUDY

7.2. SOURCES OF DATA

7.2.1.   PRIMARY DATA SOURCES

7.2.2.   SECONDARY DATA SOURCES

7.3. RESEARCH METHODOLOGY

7.3.1.   EVALUATION OF PROPOSED MARKET

7.3.2.   IDENTIFICATION OF DATA SOURCES

7.3.3.   ASSESSMENT OF MARKET DETERMINANTS

7.3.4.   DATA COLLECTION

7.3.5.   DATA VALIDATION & ANALYSIS

            

List of Tables

TABLE 1        EUROPE NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

TABLE 2        EUROPE NEUROSTIMULATION DEVICE MARKET BY SYSTEM 2019-2027 ($ MILLION)

TABLE 3        EUROPE NEUROSTIMULATION DEVICE MARKET BY APPLICATIONS 2019-2027 ($ MILLION)

TABLE 4        EUROPE NEUROSTIMULATION DEVICE MARKET BY COUNTRY 2019-2027 ($ MILLION)

List of Figures

FIGURE 1      EUROPE NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 2      VALUE CHAIN OUTLOOK

FIGURE 3      NEUROSTIMULATION DEVICE COMPANY MARKET SHARE OUTLOOK 2018 (%)

FIGURE 4      EUROPE NEUROSTIMULATION DEVICE MARKET BY SPINAL CORD STIMULATORS 2019-2027 ($ MILLION)

FIGURE 5      EUROPE NEUROSTIMULATION DEVICE MARKET BY DEEP BRAIN STIMULATORS 2019-2027 ($ MILLION)

FIGURE 6      EUROPE NEUROSTIMULATION DEVICE MARKET BY SACRAL NERVE STIMULATORS 2019-2027 ($ MILLION)

FIGURE 7      EUROPE NEUROSTIMULATION DEVICE MARKET BY VAGUS NERVE STIMULATORS 2019-2027 ($ MILLION)

FIGURE 8      EUROPE NEUROSTIMULATION DEVICE MARKET BY GASTRIC ELECTRIC STIMULATOR 2019-2027 ($ MILLION)

FIGURE 9      EUROPE NEUROSTIMULATION DEVICE MARKET BY OTHER SYSTEM 2019-2027 ($ MILLION)

FIGURE 10   EUROPE NEUROSTIMULATION DEVICE MARKET BY PAIN MANAGEMENT 2019-2027 ($ MILLION)

FIGURE 11   EUROPE NEUROSTIMULATION DEVICE MARKET BY EPILEPSY 2019-2027 ($ MILLION)

FIGURE 12   EUROPE NEUROSTIMULATION DEVICE MARKET BY ESSENTIAL TREMOR 2019-2027 ($ MILLION)

FIGURE 13   EUROPE NEUROSTIMULATION DEVICE MARKET BY URINARY AND FECAL INCONTINENCE 2019-2027 ($ MILLION)

FIGURE 14   EUROPE NEUROSTIMULATION DEVICE MARKET BY DEPRESSION 2019-2027 ($ MILLION)

FIGURE 15   EUROPE NEUROSTIMULATION DEVICE MARKET BY DYSTONIA 2019-2027 ($ MILLION)

FIGURE 16   EUROPE NEUROSTIMULATION DEVICE MARKET BY GASTROPARESIS 2019-2027 ($ MILLION)

FIGURE 17   EUROPE NEUROSTIMULATION DEVICE MARKET BY PARKINSON’S DISEASE 2019-2027 ($ MILLION)

FIGURE 18   EUROPE NEUROSTIMULATION DEVICE MARKET BY OTHER APPLICATIONS 2019-2027 ($ MILLION)

FIGURE 19   THE UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 20   FRANCE NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 21   GERMANY NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 22   SPAIN NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 23   ITALY NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 24   RUSSIA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 25   REST OF EUROPE NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying